June qualified in medicine at Oxford University, and undertook postgraduate research leading to an MSc in pharmacology. After general medical posts and Membership of the Royal Colleges of Physicians (MRCP), she joined the then Medicines Division in 1985, and has worked in several licensing areas including the Review of Medicines, new drugs and abridged.

June has worked on a wide range of topics from paracetamol toxicity to paediatric medicines, patient information to proactive pharmacovigilance. She now chairs the European Pharmacovigilance Working Party, and in the last five years has been closely involved in developing the European Risk Management strategy with other agencies.

Jan MacDonald is a pharmacist by profession and is currently Group Manager for the Access, Information for Medicines & Standards Group in the Vigilance and Risk Management of Medicines Division at the MHRA. Jan has undertaken number of assessment and management roles within the agency. Prior to this she was principal pharmacist for quality assurance and quality control in the NHS.

Beryl Keeley has a background in biochemistry and has worked in various areas in Government and previously in the pharmaceutical industry. Currently Beryl is Advertising Standards Unit Manager within the Access and Information for Medicines and Standards (AIMS) Group at the Medicines and Healthcare products Regulatory Agency with responsibility for the regulation of medicines advertising.

Dr Max Lagnado graduated with a medical degree from University College London and was a general practitioner before working for the pharmaceutical industry, primarily in medical affairs. At the MHRA, Max assesses the benefit risk of oncology products and assists the Advertising Standards Unit with the assessment of promotional materials.

Dr Rafe Suvarna worked initially as a clinician and was a medical officer in the RAF from 1989 to 1996, specialising in Aviation Medicine and General Practice. After leaving the RAF, Rafe worked in the pharmaceutical industry for three years before moving to the then MCA in January 2000 and is currently alternate UK member of the Pharmacovigilance Risk Assessment Committee (PRAC).

Etta Logan is the Deputy Director to the Prescription Medicines Code of Practice Authority (PMCPA) having joined the Authority in 1998. Etta provides legal guidance to the Authority and is a member of the Code of Practice Panel, the body which makes initial rulings upon all complaints submitted to the PMCPA.

Etta is a Solicitor having joined the Authority from private practice where she specialised in professional indemnity and medical negligence litigation.

Dr Julia Coombes completed her BSc in Physiology and PhD at the University of Edinburgh. Following this, she took up two post-doctoral research positions at the National Institute for Medical Research (NIMR) and St Mary’s Hospital, Paddington. She joined the MHRA (MCA at the time) in July 1995 as a scientific assessor with the Product Information Quality Unit. She now manages the Product Information Quality Unit with a team of eleven assessors. The Unit assesses labels and leaflet provided with licensed medicines, Type 1B safety variations and handles complaints and enquiries from healthcare professionals, patients and the pharmaceutical industry.

With a preference for working proactively with advertisers, Kate joined the PAGB as their Advertising Service Manager in June 2016 following her previous role as a Senior Executive for the Advertising Standards Authority. Her role at PAGB includes managing the Copy Clearance team who review over 8000 pieces of medicines, medical device and food advertising copy a year for compliance with PAGB Codes and Guidelines. Kate holds a 1st class BA (Hons) in Culture, Media and Communication and through her new role has built upon her broad knowledge of advertising self-regulation.

Colette is a Self-Medication Specialist and Heads up the Self Medication Unit in the Access and Information for Medicines & Standards Group at the MHRA. Before joining the MHRA Colette worked for 22 years at the National Pharmacy Association (NPA), which represents community pharmacists in the UK. Before joining the NPA, Colette worked as a community pharmacist in both the UK and in Switzerland. In 2009, Colette was designated as a Fellow of the Royal Pharmaceutical Society for distinction in the field of pharmacy practice.